Glad they mention both sides of risks if scheme is voted for or against
ResApp’s share price may fall if the Scheme does not proceed
They talked about scheme announcement added value if voted no if might fall back
Are you serious as if we know nothing about RAP???
The share increase is caused by Pfizer recognition on RAP Covid-19 value, the Scheme has limited and capped SP to an extent that all other RAP development cannot gain market value. Please put in the other group ie Share price may increase if the Scheme does not proceed
I doubt TK and board cannot confront us on questions like this "Why in regards of Pfizer's interest is only for RAP Covid Screen, the board are more decided in selling the whole company, rather than signing exclusive deal with Pfizer which will create more market premium?"
Vote them down, we need SP back to where it should be, with Pfizer as a genuine partner!
Glad they mention both sides of risks if scheme is voted for or...
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #